Fibrinogen Bastia (γ 318 Asp → Tyr) a Novel Abnormal Fibrinogen Characterized by Defective Fibrin Polymerization

Summary A new congenital dysfibrinogen, Fibrinogen Bastia, was discovered in a 20-year-old woman with no clinical symptoms. The plasma thrombin-clotting time was severely prolonged. The functional plasma fibrinogen concentration was low (0.2 mg/ml), whereas the immunological concentration was normal (2.9 mg/ml). Purified fibrinogen Bastia displayed a markedly prolonged thrombin-clotting time related to a delayed thrombin-induced fibrin polymerization. Both the thrombin-clotting time and the fibrin polymerization were partially corrected by the addition of calcium ions. The anomaly of fibrinogen Bastia was found to be located in the γ-chain since by SDS-PAGE performed according to the method of Laemmli two γ-chains were detected, one normal and one with an apparently lower molecular weight. Furthermore, analysis of plasmin degradation products demonstrated that calcium ions only partially protect fibrinogen Bastia γ-chain against plasmin digestion, suggesting that the anomaly is located in the C-terminal part of the γ-chain. Sequence analysis of PCR-amplified genomic DNA fragments of the propositus demonstrated a single base substitution (G → T) in the exon VIII of the γ chain gene, resulting in the amino acid substitution 318 Asp (GAC) → Tyr (TAC). The PCR clones were recloned and 50% of them contained the mutation, indicating that the patient was heterozygous. These data indicate that residue Asp 318 is important for normal fibrin polymerization and the protective effect of calcium ions against plasmin degradation of the C-terminal part of the γ-chain.

[1]  S. Lord,et al.  γ-Chain Dysfibrinogenemias: Molecular Structure-Function Relationships of Naturally Occurring Mutations in the γ Chain of Human Fibrinogen , 1998 .

[2]  R. Doolittle,et al.  Crystal structure of fragment double-D from human fibrin with two different bound ligands. , 1998, Biochemistry.

[3]  R. Doolittle,et al.  Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin , 1997, Nature.

[4]  E. Davie,et al.  Crystal structure of a 30 kDa C-terminal fragment from the γ chain of human fibrinogen , 1997 .

[5]  R. Doolittle,et al.  Photoaffinity labeling of the primary fibrin polymerization site: isolation and characterization of a labeled cyanogen bromide fragment corresponding to gamma-chain residues 337-379. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[6]  H. Hirata,et al.  Characterization of an abnormal fibrinogen Osaka V with the replacement of gamma-arginine 375 by glycine. The lack of high affinity calcium binding to D-domains and the lack of protective effect of calcium on fibrinolysis. , 1992, The Journal of biological chemistry.

[7]  S. Lord,et al.  A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the gamma-chain gene, causing defective calcium binding and impaired fibrin polymerization. , 1991, The Journal of biological chemistry.

[8]  M. Matsuda,et al.  Fibrinogen Kyoto III: a congenital dysfibrinogen with a gamma aspartic acid-330 to tyrosine substitution manifesting impaired fibrin monomer polymerization , 1989 .

[9]  J. Takamatsu,et al.  Fibrinogen Nagoya, a replacement of glutamine-329 by arginine in the gamma-chain that impairs the polymerization of fibrin monomer. , 1989, Journal of biochemistry.

[10]  M. Matsuda,et al.  Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site. , 1988, Journal of Biological Chemistry.

[11]  W. Bell,et al.  Fibrinogen Baltimore III: Congenital dysfibrinogenemia with a shortened γ-subunit , 1988 .

[12]  J. Soria,et al.  Fibrinogen Haifa: Fibrinogen Variant with Absence of Protective Effect of Calcium on Plasmin Degradation of Gamma Chains , 1987, Thrombosis and Haemostasis.

[13]  H. Scheraga,et al.  Localization of segments essential for polymerization and for calcium binding in the gamma-chain of human fibrinogen. , 1986, Biochemistry.

[14]  C. Dang,et al.  Localization of a fibrinogen calcium binding site between gamma-subunit positions 311 and 336 by terbium fluorescence. , 1985, The Journal of biological chemistry.

[15]  J. Soria,et al.  Platelet aggregation occurs in congenital afibrinogenaemia despite the absence of fibrinogen or its fragments in plasma and platelets, as demonstrated by immunoenzymology , 1985, British journal of haematology.

[16]  R. Doolittle,et al.  Lamprey fibrinogen gamma chain: cloning, cDNA sequencing, and general characterization. , 1985, Biochemistry.

[17]  J. Mcdonagh,et al.  CALCIUM ION FUNCTIONS IN FIBRINOGEN CONVERSION TO FIBRIN * , 1983, Annals of the New York Academy of Sciences.

[18]  W. Nieuwenhuizen,et al.  CALCIUM‐BINDING REGIONS IN FIBRINOGEN * , 1983, Annals of the New York Academy of Sciences.

[19]  G. Crabtree,et al.  Organization of the rat γ-fibrinogen gene: Alternative mRNA splice patterns produce the γA and γB (γ′) chains of fibrinogen , 1982, Cell.

[20]  W. Nieuwenhuizen,et al.  A fibrinogen fragment D (D intermediate) with calcium binding but without anticlotting properties. , 1982, Biochimica et biophysica acta.

[21]  W. Nieuwenhuizen,et al.  Recalculation of calcium-binding properties of human and rat fibrin(ogen) and their degradation products. , 1981, Thrombosis research.

[22]  A. Laudano,et al.  Influence of calcium ion on the binding of fibrin amino terminal peptides to fibrinogen. , 1981, Science.

[23]  W. Nieuwenhuizen,et al.  Anticoagulant And Calcium-Binding Properties Of High Molecular Weight Derivatives Of Human Fibrinogen, Produced By Plasmin (Fragments X) , 1981, Thrombosis and Haemostasis.

[24]  S. Olexa,et al.  Evidence for four different polymerization sites involved in human fibrin formation. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[25]  K. Nikaido,et al.  A single amino acid substitution in a histidine-transport protein drastically alters its mobility in sodium dodecyl sulfate-polyacrylamide gel electrophoresis. , 1979, Biochemistry.

[26]  W. D. de Jong,et al.  Influence of single amino acid substitutions on electrophoretic mobility of sodium dodecyl sulfate-protein complexes. , 1978, Biochemical and biophysical research communications.

[27]  F. Haverkate,et al.  Protective effect of calcium in the plasmin degradation of fibrinogen and fibrin fragments D. , 1977, Thrombosis research.

[28]  S. Pizzo,et al.  The effect of fibrin-stabilizing factor on the subunit structure of human fibrin. , 1971, The Journal of clinical investigation.

[29]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[30]  K. Weber,et al.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. , 1969, The Journal of biological chemistry.

[31]  A. Clauss,et al.  Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens , 1957 .